Table 4.
Protein | Peptide counta |
CR/control ratiob | |
---|---|---|---|
CR (7 runs) | Control (8 runs) | ||
Pga31 | 14 | ND | |
Sap9 | 6 | ND | |
Pir1 | 6 | 1 | 6.9 |
Phr2 | 12 | 3 | 4.6 |
Sod5 | 18 | 9 | 2.3 |
Utr2 | 22 | 11 | 2.3 |
Phr1 | 33 | 17 | 2.2 |
Rhd3 | 21 | 11 | 2.2 |
Rbt5 | 7 | 4 | 2.0 |
Crh11 | 51 | 33 | 1.8 |
Ecm33 | 35 | 23 | 1.7 |
Mp65 | 19 | 14 | 1.6 |
Ywp1 | 7 | 8 | 1.0 |
Cht2 | 20 | 25 | 0.9 |
Pga4 | 9 | 12 | 0.9 |
Sod4 | 12 | 22 | 0.6 |
Ssr1 | 7 | 15 | 0.5 |
Als3 | ND | 8 |
Number of tryptic peptides. Four biological replicates were analyzed for both conditions. Each biological replicate was analyzed twice (giving a maximum of 8 runs), except for Congo red, where biological replicate 1 was analyzed only once (7 runs). Congo red (CR) was used at 2 mg/liter. For sequence information of the peptides identified in control and in FCZ-treated cultures, see Tables S5 and S6, respectively, in the supplemental material. ND, not detected.
The ratios are normalized for the number of runs.